News & Events Press Releases Events & Presentations Year None201920182017 10.01 2019 Translate Bio Announces Upcoming MRT5005 Presentations at the 33rd Annual North American Cystic Fibrosis Conference 09.30 2019 Translate Bio to Present at the 3rd Annual Chardan Genetic Medicines Conference 09.17 2019 Translate Bio Announces Pricing of Public Offering of Common Stock 09.17 2019 Translate Bio Announces Proposed Public Offering of Common Stock 09.12 2019 Translate Bio Announces Strategic Manufacturing Agreement with AMRI in Support of Messenger RNA (mRNA) Manufacturing 09.09 2019 Translate Bio Announces Pipeline Program Update 07.31 2019 Translate Bio Announces Second Quarter 2019 Financial Results and Provides Corporate Update 07.31 2019 Translate Bio Announces Interim Results from Phase 1/2 Clinical Trial of MRT5005 in Patients with Cystic Fibrosis 07.15 2019 Translate Bio Appoints George Demetri, M.D., to its Board of Directors 06.26 2019 Translate Bio Announces FDA Clearance to Proceed with a Single-ascending Dose (SAD) Phase 1/2 Clinical Trial for Ornithine Transcarbamylase (OTC) Deficiency Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Displaying 1 - 10 of 28 Presentations Corporate Presentation 2.2 MB Upcoming Events 10.30 2019 North American Cystic Fibrosis Conference (NACFC) 11.10 2019 7th International mRNA Health Conference Past Events 10.07 2019 3rd Annual Chardan Genetic Medicines Conference 09.03 2019 Citi’s 14th Annual Biotech Conference 08.06 2019 SVB Leerink Spotlight Series: Rare & Genetic Diseases 07.31 2019 Translate Bio Conference Call 06.27 2019 2019 RNA Therapeutics Conference 06.03 2019 Jefferies 2019 Healthcare Conference 04.28 2019 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting 04.15 2019 World Vaccine Congress 04.09 2019 18th Annual Needham Healthcare Conference 04.07 2019 Keystone Symposia: Protein Replacement through Nucleic Acid Therapies Pagination Current page 1 Page 2 Page 3 Page 4 Next page next › Last page last »
